Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study.

Lennon AM, Manos LL, Hruban RH, Ali SZ, Fishman EK, Kamel IR, Raman SP, Zaheer A, Hutfless S, Salamone A, Kiswani V, Ahuja N, Makary MA, Weiss MJ, Hirose K, Goggins M, Wolfgang CL.

Ann Surg Oncol. 2014 Oct;21(11):3668-74. doi: 10.1245/s10434-014-3739-x. Epub 2014 May 8.

2.

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.

Gut. 2002 Nov;51(5):717-22.

3.
4.

Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation.

Lafemina J, Katabi N, Klimstra D, Correa-Gallego C, Gaujoux S, Kingham TP, Dematteo RP, Fong Y, D'Angelica MI, Jarnagin WR, Do RK, Brennan MF, Allen PJ.

Ann Surg Oncol. 2013 Feb;20(2):440-7. doi: 10.1245/s10434-012-2702-y. Epub 2012 Oct 31.

PMID:
23111706
5.

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9.

6.

Invasive IPMN and MCN: same organ, different outcomes?

Kargozaran H, Vu V, Ray P, Bagaria S, Steen S, Ye X, Gagandeep S.

Ann Surg Oncol. 2011 Feb;18(2):345-51. doi: 10.1245/s10434-010-1309-4. Epub 2010 Aug 31.

PMID:
20809175
7.

Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up.

Xourafas D, Tavakkoli A, Clancy TE, Ashley SW.

Surgery. 2015 Mar;157(3):473-83. doi: 10.1016/j.surg.2014.09.028. Epub 2015 Jan 14.

PMID:
25596773
8.

Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.

Marchegiani G, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.

J Am Coll Surg. 2015 May;220(5):839-44. doi: 10.1016/j.jamcollsurg.2015.01.051. Epub 2015 Feb 11.

PMID:
25840549
9.

Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.

Fritz S, Schirren M, Klauss M, Bergmann F, Hackert T, Hartwig W, Strobel O, Grenacher L, Büchler MW, Werner J.

Surgery. 2012 Sep;152(3 Suppl 1):S74-80. doi: 10.1016/j.surg.2012.05.025. Epub 2012 Jul 6.

PMID:
22770954
10.

[Surgical aspects of intraductal papillary mucinous neoplasm of the pancreas].

Oláh A.

Magy Seb. 2014 Apr;67(2):39-43. doi: 10.1556/MaSeb.67.2014.2.1. Hungarian.

PMID:
24747402
11.

Laparoscopic Hand-Assisted Parenchymal-Sparing Resections for Presumed Side-Branch Intraductal Papillary Mucinous Neoplasms.

Thomas E, Matsuoka L, Alexopoulos S, Selby R, Parekh D.

J Laparoendosc Adv Surg Tech A. 2015 Aug;25(8):668-71. doi: 10.1089/lap.2014.0669. Epub 2015 Jul 22.

PMID:
26200132
12.

Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.

Yamada S, Fujii T, Shimoyama Y, Kanda M, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Nakao A, Kodera Y.

Ann Surg Oncol. 2014 Jul;21(7):2444-52. doi: 10.1245/s10434-014-3565-1. Epub 2014 Feb 22.

PMID:
24562937
13.

Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.

Sadakari Y, Ienaga J, Kobayashi K, Miyasaka Y, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Pancreas. 2010 Mar;39(2):232-6. doi: 10.1097/MPA.0b013e3181bab60e.

PMID:
19752768
14.

Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.

Fan F, Lai EC, Xie F, Yang JM, Xu F, Kan T, Shen RX, Yang XY, Lau Wan Y, Wu MC.

Hepatogastroenterology. 2010 May-Jun;57(99-100):635-9.

PMID:
20698241
15.

Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.

Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H.

Arch Surg. 2009 Apr;144(4):345-9; discussion 349-50. doi: 10.1001/archsurg.2009.2.

PMID:
19380648
16.

Primary pancreatic cystic neoplasms revisited. Part III. Intraductal papillary mucinous neoplasms.

Sakorafas GH, Smyrniotis V, Reid-Lombardo KM, Sarr MG.

Surg Oncol. 2011 Jun;20(2):e109-18. doi: 10.1016/j.suronc.2011.01.004. Epub 2011 Mar 10. Review.

PMID:
21396811
17.

[Differentiated therapy for intraductal papillary mucinous neoplasms].

Wente MN, Schmied BM, Schmidt J, Büchler MW.

Chirurg. 2009 Jan;80(1):7-13. doi: 10.1007/s00104-008-1579-6. Review. German.

PMID:
19082569
18.

Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.

Sahora K, Mino-Kenudson M, Brugge W, Thayer SP, Ferrone CR, Sahani D, Pitman MB, Warshaw AL, Lillemoe KD, Fernandez-del Castillo CF.

Ann Surg. 2013 Sep;258(3):466-75. doi: 10.1097/SLA.0b013e3182a18f48.

PMID:
24022439
19.

Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.

Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.

J Clin Gastroenterol. 2006 Oct;40(9):856-62.

PMID:
17016145
20.

Pancreatic Resection for Side-Branch Intraductal Papillary Mucinous Neoplasm (SB-IPMN): a Contemporary Single-Institution Experience.

Dortch JD, Stauffer JA, Asbun HJ.

J Gastrointest Surg. 2015 Sep;19(9):1603-9. doi: 10.1007/s11605-015-2851-y. Epub 2015 Jun 9.

PMID:
26055134

Supplemental Content

Support Center